Global Hematology Oncology Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 8.13 Billion |
 Market Size (Forecast Year) |
USD 14.83 Billion |
 CAGR |
% |
| Major Markets Players |
>全球血液肿瘤学市场，按血液学产品（血液学分析仪、血液学试剂、流式细胞仪、血液学细胞计数器、载玻片过滤器、凝血分析仪、血液学检测、离心机、血红蛋白计等）、肿瘤学药物类别类型（化疗、靶向治疗、免疫治疗、激素治疗）、肿瘤适应症（肺癌、胃癌、结直肠癌、乳腺癌、前列腺癌、肝癌、食道癌、宫颈癌、肾癌、膀胱癌等）、应用（传染病、癌症、心血管疾病、血液筛查、糖尿病、艾滋病毒、自身免疫性疾病）、最终用户（医院、临床检测机构、患者自我检测、其他最终用户）划分 – 行业趋势和预测到 2029 年
血液肿瘤学市场分析和规模
预计血液肿瘤学市场将在 2022-2029 年的预测期内增长。全球范围内骨髓瘤和淋巴瘤发病率的上升是血液肿瘤学市场收入增长的主要驱动力之一。由于开发成本上升以及基因组学领域人类基因组计划 (HGP) 的测序，下一代测序 (NGS) 等测序技术的普及，市场扩张前景也在改善，因为用于诊断血液肿瘤的更好的分子技术的可及性有所提高。
Data Bridge Market Research 分析，血液肿瘤市场规模在 2021 年为 81.3 亿美元，到 2029 年将飙升至 148.3 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 7.80%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
Hematology Product (Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Hematology Testing, Centrifuges, Hemoglobin meters, Others), Oncology Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), Oncology Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others), Applications (Infectious Diseases, Cancer, Cardiovascular Disorders, Blood Screening, Diabetes, HIV, Auto – Immune Diseases), End Users (Hospitals, Clinical Testing Institutes, Patient Self- Testing, Other End- Users) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies Inc. (U.S.), Myriad Genetics Inc. (U.S.), Beijing Genomics Institute (BGI), Perkin Elmer Inc. (U.S.), Foundation Medicine Inc. (U.S.), PacBio (U.S.), Oxford Nanopore Technologies plc. (U.K.), Paradigm Diagnostics Inc. (U.S.), Caris Life Sciences (Japan), Partek, Incorporated (U.S.), Eurofins Scientific (Luxembourg), Qiagen (Germany) |
|
Market Opportunities |
|
Market Definition
Hematology is the study of blood and bone marrow illnesses and includes their diagnosis, prevention, and therapy. The field of medicine known as oncology is primarily concerned with treating and diagnosing cancer. Hematology is commonly used in treatments for conditions including diabetes, cancer, cardiovascular disease, and blood screening, among others. The three main fields of oncology are medicine, surgery, and radiation.
Global Hematology Oncology Market Dynamics
Drivers
- Rise in the prevalence of lymphoma and myeloma
The main factors propelling the expansion of the haematology oncology market is the rise in the prevalence of lymphoma and myeloma around the world. The creation and sequencing of the Human Genome Project has become more expensive, leading to a proliferation of sequencing methods like NGS. The availability of more sophisticated molecular techniques for the diagnosis of hemato oncology has also increased. The advent of cutting-edge molecular approaches to address issues with blood cancer prognosis, course of therapy, and diagnostics, as well as the rise in cases of blood disorders, have a further impact on the market.
- Rise in healthcare infrastructure
The haematology oncology market is benefited by advantageous reimbursement policies, pharmaceutical industry cooperation, and the rise in healthcare spending. Increasing investment for healthcare infrastructure. This boosts the market.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like as rising healthcare spending, and the fast-growing diagnostic industry, are driving the worldwide hematology oncology market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the hematology oncology market forward.
Opportunities
- Rise in cases of blood disorders
The hematology oncology market's growth is fuelled by the advent of cutting-edge molecular approaches to address issues with blood cancer prognosis, course of therapy, and diagnostics, as well as the rise in cases of blood disorders. This will provide beneficial opportunities for the hematology oncology market growth.
Moreover, an increase in the number of emerging markets and new product launches will further provide beneficial opportunities for the growth of hematology oncology market during the forecast period.
Restraints/Challenges
- High cost
On the other hand, the high cost associated with the cancer drugs will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the hematology oncology market.
This hematology oncology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hematology oncology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Hematology Oncology Market
COVID-19 疫情对市场造成了轻微损害。为了测量 COVID-19，血液学标准受到更广泛的重视。许多医院已经使用血液分析仪等仪器对 COVID-19 患者进行了测试并进行了跟踪。只有临床血液学实验室才能提供重要的预后指标，例如淋巴细胞减少、中性粒细胞增多、白细胞增多和血小板减少——这些都是 SARS-CoV-2 病毒患者的常见表现。此外，COVID-19 和镰状细胞病 (SCD) 患者更有可能住院、出现肺炎和疼痛。SCD 患者需要密切监测自己的健康状况，因为他们更容易感染新感染。这对市场产生了巨大影响。
近期发展
- 2022 年 6 月，赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.) 扩大了其广泛的自动化结缔组织疾病检测产品线，推出了新的 EliA RNA Pol III 和 EliA Rib-P 血液检测，以协助诊断系统性硬化症和系统性红斑狼疮 (SLE)。
- 2020年5月，美国丹纳赫集团旗下的贝克曼库尔特公司推出了DxH 690T血液分析仪。它使中等规模的实验室能够优化正常运行时间并简化工作流程。
全球血液肿瘤学市场范围
血液肿瘤学市场根据血液学产品、肿瘤药物类别、肿瘤适应症、应用和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
血液学产品
- 血液学分析仪
- 血液学试剂
- 流式细胞仪
- 血液学细胞计数器
- 滑动滤网
- 凝血分析仪
- 血液学检测
- 离心机
- 血红蛋白仪
- 其他的
肿瘤药物类别类型
- 化疗
- 靶向治疗
- 免疫疗法
- 激素治疗
肿瘤适应症
- 肺癌
- 胃癌
- 结直肠癌
- 乳腺癌
- 前列腺癌
- 肝癌
- 食道癌
- 宫颈癌
- 肾癌
- 膀胱癌
- 其他的
应用
- 传染病
- 癌症
- 心血管疾病
- 血液检查
- 糖尿病
- 艾滋病病毒
- 自身免疫性疾病
最终用户
- 医院
- 临床检测机构
- 患者自我检测
- 其他最终用户
血液肿瘤学市场区域分析/见解
对血液肿瘤学市场进行了分析，并按国家、血液学产品、肿瘤药物类别、肿瘤适应症、应用和最终用户提供了市场规模见解和趋势。
血液肿瘤市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于北美白血病、淋巴瘤和多发性骨髓瘤发病率上升，北美在血液肿瘤市场占据主导地位。
由于该地区各学术研究机构开展的研究活动不断增加，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和血液肿瘤学市场份额分析
血液肿瘤学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对血液肿瘤学市场的关注有关。
血液肿瘤学市场的一些主要参与者包括：
- Illumina 公司（美国）
- 赛默飞世尔科技公司（美国）
- F. Hoffmann-La Roche Ltd.（瑞士）
- 安捷伦科技公司（美国）
- Myriad Genetics Inc.（美国）
- 北京基因组研究所（BGI）
- Perkin Elmer Inc.（美国）
- Foundation Medicine Inc.（美国）
- PacBio (美国)
- 牛津纳米孔技术有限公司（英国）
- Paradigm Diagnostics Inc.（美国）
- Caris Life Sciences（日本）
- Partek, Incorporated（美国）
- Eurofins Scientific（卢森堡）
- Qiagen (德国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
